Keynote

1. Director
2. Visiting Associate Professor
3. Founder

1. Ando Orofacial Pain & Oral Medicine Center
2. Showa University School of Dentistry
3. Spark Medical

Orofacial pain and oral medicine

• 2010: Doctor of Dental Surgery, Showa University School of Dentistry
• 2011: Internship, Prosthodontics/TMD and Oral Surgery at Showa University Dental Hospital
• 2013: Residency Program at Orofacial Pain & Oral Medicine Center at University of Southern California, Herman Ostrow School of Dentistry.

• American Academy of Orofacial Pain
• American Academy of Oral Medicine
• American Headache Society
• International Association for the Study of Pain

1. Noboru N, Ando A. (2019) “Q&A Column of Dental, Oral, and Jaw Pain” Hyoron Publishers (JPN).
2. Ando A, Takagi H. (2018 Jan – Dec) “Spark Medical Presents: Clinical English Café” Quintessence Publishing (JPN).
3. Noboru N, Ando A. (2017 Apr – Aug) “Diagnosing Orofacial Pain” Hyoron Publishers (JPN).
4. Ando A. (2017 Jan – Dec). “Spark the Interest. Keys to Make an Impressive Presentations” Quintessence Publishing (JPN).
5. Yuasa H, Ando A, Miyashita H, Nagao T, Ogi K. (2015) “Myths and the Facts in Extraction, Minor Surgery, TMD, and Mucosal Disease” Quintessence Publishing (JPN).

Keynote

Professor

Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University

1. Biomedical Statistics
2. Epidemiology
3. Preventive Medicine

1. 1998, Ph.D. in Biostatistics, Biostatistics Unit of Medical Research Council (MRC), Institute of Public Health, Cambridge University, UK
2. 1992, M.Phil. in Biostatistics, Biostatistics Unit of Medical Research Council (MRC), Institute of Public Health, Cambridge University, UK
3. 1988, M.Sc. in Epidemiology, College of Public Health, National Yang-Ming University
4. 1986, DDS in School of Dentistry, Taipei Medical University

1. -till now, Professor, Division of Biostatistics, College of Public Health National Taiwan, National Taiwan University
2. -till now, Professor, Department of Public Health, National Taiwan University
3. 2017-till now, Member, Office of Research and Development, National Taiwan University
4. 2017-2020, Associate Dean, College of Public Health, National Taiwan University
5. 2017-2020, Director, Master of Public Health Program, College of Public Health, National

1. 2007-2009, Finnish Distinguished Professor (FIDIPRO), Academy of Finland)
2. 2003, Ching-Xing Medical Award, Ching-Xing Medical Science Culture and Educatione Foundation, ROC
3. 2001, Distinguished Research Award of National Science Council

Special Issue in Periodicals

1. Chen HH, Huang LM (Guest Editor). Special Issue “COVID-19 Pandemic: Challenges and Opportunities”, J Formosan Medical Association, June, 2021. [SCI]

Selected peer-reviewed papers

1. Jen GHH, Yen AMF, Hsu CY, Chiu HM, Chen SLS*, Chen THH*. Modelling the Impacts of COVID-19 Pandemic on the Quality of Population-based Colorectal Cancer Screening. Prev Med 2021 (Accepted). [SCI] (Corresponding Author)
2. Jen HH, Chang WJ, Lin TY, Hsu CY, Yen AM, Lai CC, Chen TH*. Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach. Infect Dis Ther. 2021 Mar 18:1-11. doi: 10.1007/s40121-021-00431-9. [SCI] (Corresponding author)
3. Lai CC, Hsu CY, Jen HH, Yen AM, Chan CC, Chen HH. The Bayesian Susceptible-Exposed-Infected-Recovered model for the outbreak of COVID-19 on the Diamond Princess Cruise Ship. Stoch Environ Res Risk Assess. 2021 Jan 26:1-15. doi: 10.1007/s00477-020-01968-w.
4. Chiu HM, Su CW, Hsu WF, Jen GH, Hsu CY, Chen SL, Chen HH. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region. Prev Med. 2021 Oct;151:106622. doi: 10.1016/j.ypmed.2021.106622.
5. Fan CY, Fann JC, Yang MC, Lin TY, Chen HH, Liu JT, Yang KC*. Estimating global burden of COVID-19 with disability-adjusted life years and value of statistical life metrics. J Formos Med Assoc. 2021 Jun;120 Suppl 1:S106-S117. doi: 10.1016/j.jfma.2021.05.019. [SCI]
6. Wang WC, Fann JC, Chang RE, Jeng YC, Hsu CY, Chen HH, Liu JT, Yen AM*. Economic evaluation for mass vaccination against COVID-19. J Formos Med Assoc. 2021 Jun;120 Suppl 1:S95-S105. doi: 10.1016/j.jfma.2021.05.020. [SCI]
7. Wang WC, Lin TY, Chiu SY, Chen CN, Sarakarn P, Ibrahim M, Chen SL, Chen HH, Yeh YP*. Classification of community-acquired outbreaks for the global transmission of COVID-19: Machine learning and statistical model analysis. J Formos Med Assoc. 2021 Jun;120 Suppl 1:S26-S37. doi: 10.1016/j.jfma.2021.05.010. [SCI]
8. Chen HH*, Kao JH, Chen JS, Ni YH. What we have learned from COVID-19 pandemic? J Formos Med Assoc. 2021 Jun;120 Suppl 1:S1-S5. doi: 10.1016/j.jfma.2021.06.005. [SCI]
9. Hu TH, Su WW, Yang CC, Yang CC, Kuo WH, Chen YY, Yeh YH, Chen SS, Tsao YY, Chen KM, Yan SL, Lai JH, Yao CD, Lim CH, Jen HH, Yeh YP*, Chen SLS, Chen HH, Chen SC; Changhua Hepatitis C Elimination Task Force. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan. Am J Kidney Dis. 2021 Apr 30:S0272-6386(21)00575-8. doi: 10.1053/j.ajkd.2021.03.017.
10. Chiang TH, Maeda M, Yamada H, Chan CC, Chen SL, Chiu SY, Chen YN, Chou YH, Shieh CF, Liu CY, Chiu HM, Chiang H, Shun CT, Lin MW, Wu MS, Lin JT, Chen HH, Ushijima T, Graham DY, Lee YC. Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands. J Gastroenterol Hepatol. 2021 Mar;36(3):671-679. doi: 10.1111/jgh.15187.
11. Chiang TH, Chang WJ, Chen SL, Yen AM, Fann JC, Chiu SY, Chen YR, Chuang SL, Shieh CF, Liu CY, Chiu HM, Chiang H, Shun CT, Lin MW, Wu MS, Lin JT, Chan CC, Graham DY, Chen HH, Lee YC. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut. 2021 Feb;70(2):243-250. doi: 10.1136/gutjnl-2020-322200.
12. Chen SLS, Yen AMF, Lai CC, Hsu CY, Chan CC, & Chen HH*. An Index for Lifting Social Distancing During the COVID-19 Pandemic: Algorithm Recommendation for Lifting Social Distancing. Journal of medical Internet research, 2020, 22(9), e22469.
13. Chen CM, Jyan HW, Chien SC, Jen HH, Hsu CY, Lee PC, …& Chen HH, Chan CC. Containing COVID-19 among 627,386 persons in contact with the diamond princess cruise ship passengers who disembarked in Taiwan: big data analytics. Journal of Medical Internet Research, 2020, 22.5: e19540.
14. Fann JC, Chang KJ, Hsu CY, Yen AM, Yu CP, Chen SL, Kuo WH, Tabár L, Chen HH*. Impact of Overdiagnosis on Long-Term Breast Cancer Survival. Cancers (Basel). 2019 Mar 7;11(3). pii: E325. doi: 10.3390/cancers11030325.
15. Ku MS, Fann JC, Chiu SY, Chen HH, Hsu CY. Elucidating bidirectional relationship between metabolic syndrome and elevated faecal haemoglobin concentration: a Taiwanese community-based cohort study. BMJ Open. 2019 Mar 1;9(3):e021153. doi: 10.1136/bmjopen-2017-021153.
16. Yang KC, Hung HF, Chen MK, Chen SL, Fann JC, Chiu SY, Yen AM, Huang KC, Chen HH, Wang ST. Cost-effectiveness analysis of universal influenza vaccination: Application of the susceptible-infectious-complication-recovery model. Int J Infect Dis. 2018 Aug;73:102-108. doi: 10.1016/j.ijid.2018.05.024.
17. Hsu CY, Yen MF, Auvinen A, Chiu YH, Chen HH*. Bayesian negative-binomial-family-based multistate Markov model for the evaluation of periodic population-based cancer screening considering incomplete information and measurement errors. Stat Methods Medical Research 2018 Aug;27(8):2519-2539. [SCI] (Corresponding Author)
18. Yang YM, Hsu CY, Lai CC, Yen MF, Wikramaratna PS, Chen HH*, Wang TH. Impact of Comorbidity on Fatality Rate of Patients with Middle East Respiratory Syndrome. Sci Rep. 2017 Sep 12;7(1):11307. doi: 10.1038/s41598-017-10402-1. [SCI]
19. Lai CC, Jiang DS, Wu HM, Chen THH*. A dynamic model for the outbreaks of hand, foot, and mouth disease in Taiwan. Epidemiol Infect. 2016 May;144(7):1500-11. [SCI] (Corresponding Author)
20. Lai CC, Hsieh YC, Yeh YP,* Jou R, Wang JT, Pan SL, Chen HH. A Pulmonary Tuberculosis Outbreak in a Long-term Care Facility. Epidemiol Infection 2016 May;144(7):1455-62. [SCI]

Prof. Hsiu-Hsi Chen is an expert in evaluation of intervention program, with emphasis on population-based cancer screening and also universal vaccination program, by using a series of complex statistical modelling to deal with several thorny issues that cannot be solved by classical approaches. These include the development of different health economic decision models for cancer screening program and also vaccination program and prophylactic treatment. The recent statistical publications on the methodology of applying stochastic process to evaluation of cancer screening model published in JASA, Biometrics, and other peer review articles. A series of original articles cost-effectiveness (benefit) analysis based on these models have been published in international peer review articles.  

Regarding international academic cooperation, Professor Chen has taken the presidency of the international Asian Cancer Screening Conference (Network) held annually since 2004. As far as collaborative research in Western countries is concerned, the long-lasting collaboration with Sweden (Falun Central Hospital), the USA (American Cancer Society), United Kingdom (Wolfson Institute of Preventive Medicine), and also Finland (School of Public Health, University of Tampere) where Professor Chen was awarded the Finland Distinguished Professor (FIDIPRO) issued by the Academy of Finland between 2007 and 2009.

Keynote

Professor in Tumour Pathology

University of Bergen

Oral cancer: tumour-stroma interactions in oral squamous cell carcinoma

• 2006 – Board examination in oral pathology, Scandinavian Fellowship of Oral Pathology and Oral Medicine, Malmo, Sweden
• 2005 - Ph.D., Faculty of Medicine and Odontology, University of Bergen, Norway.
• 1997 - Master, Faculty of Dentistry, University of Medicine and Pharmacy ‘Carol Davila’, Bucharest, Romania

• 2017-present Oral Pathologist, Haukeland University Hospital, Norway
• 2014-present Professor in Tumour Pathology, Gade Laboratory for Pathology, Department of Clinical Medicine, Faculty of Medicine and Odontology, UiB, Norway
• 2013-2014       Assoc. Professor in Head and Neck Anatomy, Department of Biomedicine, UiB, Norway.
• 2010-2013       Researcher, Department of Clinical Medicine, UiB, Norway
• 2009-2020   Guest Senior Researcher, Faculty of Engineering and Biophysics, University of Surrey, UK
• 2009-2010       Assoc. Professor in Oral Pathology, Department of Clinical Medicine, UiB, Norway
• 2005-2009       Postdoctoral Research Fellow, Department of Clinical Medicine, Faculty of Medicine and Odontology, UiB, Norway
• 1998-2000       Lecturer in Oral Pathology and Oral Medicine, Faculty of Dentistry, University of Medicine and Pharmacy ‘Carol Davila’, Bucharest, Romania
• 1997-1998       Dentist, University Hospital ‘Dan Theodorescu’ Bucharest, Romania.

• 2021 – Pindborg Lecture, Scandinavian Fellowship of Oral Pathology and Oral Medicine, IAOP London
• 2018 - Investigator Award, Head & Neck Tumour Microenvironment Symposium, Essen, Germany.
• 2012 - Young Investigator Award, Head & Neck Stem Cell Symposium, Michigan, US.
• 2007 - Young Investigator Award of International Association of Oral Pathology, 13th International Congress on Oral Pathology and Medicine, Australia.
• 2006 - Meltzer Prize for Young Researchers 2005, University of Bergen, Norway.
• 2005 - Prize for Teaching & Research in Odontology, Norwegian Dental Association
• 2004 - Hatton Award, NOF Division of IADR. Joint Meeting of Continental European, Israeli, and Scandinavian (NOF) Divisions of IADR, Turkey.
• 2004 - Young Investigator Award of the Spanish Society of Oral Medicine. 12th International Congress on Oral Pathology and Medicine, Madrid, Spain.
• 2003 - Young Investigator Award, 9th International Congress on Oral Cancer, Melbourne, Australia.

1. Combined In Situ Hybridization and Immunohistochemistry on Archival Tissues Reveals Stromal microRNA-204 as Prognostic Biomarker for Oral Squamous Cell Carcinoma. Rajthala S, Dongre H, Parajuli H, Min A, Nginamau ES, Kvalheim A, Lybak S, Sapkota D, Johannessen AC, Costea DE. Cancers (Basel). 2021
2. Targeted next-generation sequencing of cancer-related genes in a Norwegian patient cohort with head and neck squamous cell carcinoma reveals novel actionable mutations and correlations with pathological parameters, Dongre H, Have H, Fromreide S, Erland FA, Moe SEE, Dhayalan SM, Riis RK, Sapkota D, Costea DE, Aarstad HJ and Vintermyr OK, Frontiers in Oncology, 2021
3. Analysis of salivary mycobiome in a cohort of oral squamous cell carcinoma patients from Sudan identifies higher salivary carriage of Malassezia as an independent and favourable predictor of overall survival, Mohamed NG, Litlekalsøy J, Ahmed IA, Martinsen EM, Furriol J, Javier-Lopez R, Elsheikh M, Gaafar NM, Lorgado L, Mundra S, Johannessen AC, Osman TA, Nginamau ES, Suleiman A, Costea DE, Front. Cell. Infect. Microbiol. 2021
4. Characterization of Immune Cell Infiltrate in Tumour Stroma and Epithelial Compartments in Oral Squamous Cell Carcinomas of Sudanese Patients, Gaafar NM, Ahmed I, Elsheikh M, Mohammed N, Johannessen AC, Osman TA, Nginamau ES, Suleiman A, Costea DE, Clinical and Experimental Dental Research. 2021
5. Helicobacter pylori was not detected in oral squamous cell carcinomas from cohorts of Norwegian and Nepalese patients. Pandey S, Follin-Arbelet B, Pun CB, Gautam DK, Johannessen AC, Petersen FC, Costea DE, Sapkota D. Sci Rep. 2020
6. A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer. Bjerkli IH, Hadler-Olsen E, Nginamau ES, Laurvik H, Søland TM, Costea DE, Uhlin-Hansen L, Steigen SE. Virchows Arch. 2020
7. Establishment of a novel cancer cell line derived from vulvar carcinoma associated with lichen sclerosus exhibiting a fibroblast-dependent tumorigenic potential. Dongre H, Rana N, Fromreide S, Rajthala S, Bøe Engelsen I, Paradis J, Gutkind JS, Vintermyr OK, Johannessen AC, Bjørge L, Costea DE. Exp Cell Res. 2020
8. Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts. Zhang Z, Gao Z, Rajthala S, Sapkota D, Dongre H, Parajuli H, Suliman S, Das R, Li L, Bindoff LA, Liang X, Costea DE Cell Mol Life Sci. 2020
9. Effect of glycerol on reconstructed human oral mucosa. Kvalheim SF, Xenaki V, Kvalheim A, Lie SA, Marthinussen MC, Strand GV, Costea DE. Eur J Oral Sci. 2019
10. Integrin α11 is overexpressed by tumour stroma of head and neck squamous cell carcinoma and correlates positively with alpha smooth muscle actin expression. Parajuli H, Teh MT, Abrahamsen S, Christoffersen I, Neppelberg E, Lybak S, Osman T, Johannessen AC, Gullberg D, Skarstein K, Costea DE. J Oral Pathol Med. 2017 

I am trained as an oral pathologist. Since year 2000 I perform research in the field of oral epithelial biology and cancer and since 2011 I also carry out surgical pathological diagnostic in oral and ear-nose-throat areas. Later on, I became interested in biomarkers and since 2016 I am Associated Investigator at Center of Excellency in Cancer Biomarkers CCBIO. CCBIO is one of the most prestigious centers of cancer research in Norway, financed by Norwegian Research Council (NFR) (https://www.uib.no/en/ccbio/107681/daniela-elena-costea ). My research interests follow two lines: an experimental one, in which I use in vitro and in vivo humanized models of normal human oral mucosa and oral cancer for deciphering the key molecular interactions between oral epithelial cells, be they normal or neoplastic, and their microenvironment; and a descriptive one, in which I use various biological samples to characterize as thorough as possible the lesions of oral cancer and the host, with the aim of identifying a method for effective stratification of cancer patients according to the biological progress and outcome of their disease (http://patexp.w.uib.no/). I have been PI or co-Investigator of several national- and EU-funded grants.

Keynote

Professor & Executive Director

Australian Centre for Oral Oncology Research & Education, Australian Clinical Labs, CQUniversity, and Peter MacCallum Cancer Centre

Oral Medicine, Oral Pathology, Oral Cancer, Oral Potentially Malignant Disorders

• BDSc, University of Western Australia, Australia
• MDSc(OralMed OralPath), University of Queensland, Australia
• FRACDS(OralMed), Royal Australasian College of Dental Surgeons
• GradCertExLead, University of Queensland, Australia
• GradCertHigherEd, University of Queensland, Australia
• PhD, University of Queensland, Australia
• MBA, Australian Institute of Management Business School, Australia

• Vice President-elect, Oral Medicine & Pathology Group, International Association for Dental Research
• Past President, International Association for Dental Research Asia Pacific Region
• Past President, International Association for Dental Research Australian & New Zealand Division
• Inaugural and Past President, Oral Medicine Academy of Australasia
• Past Chair, Australian Dental Research Foundation
• Past Vice President, Australian Immunohistochemistry Society
• Former Dean and Professor of Oral Oncology, UWA Dental School, University of Western Australia
• Former Chief Executive, Oral Health Centre of Western Australia

• 2020, Alan Docking IADR Science Award; most prestigious dental research award conferred by the ANZ IADR Division on the basis of outstanding scientific achievement in the field of dental research over a sustained period of time with assessment made on the basis of published work.
• 2019, Australia’s Research Field Leader Health & Medical Sciences - Oral & Maxillofacial Surgery; independently recognized by League of Scholars and The Australian as the leading researcher in the field of Oral & Maxillofacial Surgery based on published work in head and neck pathology and surgical oncology.
• 2007, ANZ/IADR Oral Biology Research Award; conferred on the basis of excellence in research in the broad field of oral biology with assessment made on the basis of published work.
• Fellow of International Academy of Oral Oncology, International College of Dentists, Pierre Fauchard Academy, Oral Medicine Academy of Australasia, Australian Institute of Management, Australian College of Health Service Management

1. CS Farah, S Fox, K Shearston, L Newman, S Babic, M Vacher. Lichenoid dysplasia is not a distinct pathological entity. Oral Oncol 2021;119. https://doi.org/10.1016/j.oraloncology.2021.105362
2. CS Farah, SA Fox. Dysplastic oral leukoplakia is molecularly distinct from leukoplakia without dysplasia. Oral Dis. 2019 Oct;25(7):1715-1723. doi: 10.1111/odi.13156.
3. CS Farah, M Jessri, NC Bennett, AJ Dalley, K Shearston, SA Fox. Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation. Oral Oncol. 2019 Sep;96:42-50. doi: 10.1016/j.oraloncology.2019.07.005.
4. CS Farah. Molecular, genomic and mutational landscape of oral leukoplakia. Oral Diseases 2021;27(4):803-812 https://doi.org/10.1111/odi.13608
5. CS Farah. Molecular landscape of head and neck cancer and implications for therapy. Annals of Translational Medicine 2021:9(10):915. http://dx.doi.org/10.21037/atm-20-6264
6. L Tiwari, O Kujan, CS Farah. Clinico-pathological correlation of optical fluorescence imaging in oral mucosal lesions. Oral Dis. 2020 Mar 21. doi: 10.1111/odi.13334.
7. F Kordbacheh, CS Farah. Molecular pathways and druggable targets in head and neck squamous cell carcinoma. Cancers 2021, 13, 3453. https://doi.org/ 10.3390/cancers13143453
8. CS Farah, S Fox, A Dalley. Integrated miRNA-mRNA spatial signature for oral squamous cell carcinoma: a prospective profiling study of Narrow Band Imaging guided resection. Sci Rep. 2018 Jan 16;8(1):823. doi: 10.1038/s41598-018-19341-x.
9. F Kordbacheh, N Bhatia, CS Farah. Patterns of differentially expressed genes in oral mucosal lesions visualized under autofluorescence (VELscope™). Oral Dis. 2016 May;22(4):285-96. doi: 10.1111/odi.12438. Epub 2016 Feb 9.
10. CS Farah, L McIntosh, A Georgiou, M McCullough. The efficacy of autofluorescence imaging (VELScope) in the visualisation of oral mucosal lesions. Head Neck. 2012 Jun;34(6):856-62. doi: 10.1002/hed.21834.

Professor Camile S. Farah BDSc, MDSc (OralMed OralPath), PhD, GCEd (HE), GCExLead, MBA, MAICD, AFCHSM, CHM, FRACDS (OralMed), FOMAA, FIAOO, FICD, FPFA, FAIM  is a highly accomplished executive, academic, researcher and author with 25 years’ experience in the healthcare, biotech and medical research sectors. He is dual trained oral physician and maxillofacial pathologist, with public and private appointments at Fiona Stanley Hospital, Hollywood Private Hospital, Qscan Radiology Clinics, Australian Clinical Labs, Genomics for Life, and Optiscan Imaging Ltd. Currently he is Adjunct Professor at CQUniversity and Honorary Professorial Research Fellow at the Peter MacCallum Cancer Centre. His clinical and research expertise lie in optical imaging, molecular pathology and precision medicine in head and neck cancer. Professor Farah is a leading international expert in oral cancer and precancerous pathology based on his clinical and research expertise having attracted $19.5 million in competitive research funding, published 250 papers and a bestselling textbook “Contemporary Oral Medicine” with a H-index of 45. He has mentored over 50 postgraduate students, registrars and postdoctoral fellows.  He is former Dean and Professor of Oral Oncology at the University of Western Australia Dental School, former Chair of the Australian Dental Research Foundation, former President of the Oral Medicine Academy of Australasia, and former President of the Asia Pacific Region and ANZ Division of the International Association for Dental Research. 

Keynote

Lecturer

Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University

Oral Pathology

• March 2007: PhD, Kyushu University, Graduate School of Dental Science
• April 2003-March 2007: Postgraduate Student, Kyushu University, Graduate School of Dental Science
• March 2003: DDS, Kyushu University, School of Dentistry

• April 2020-Present: Lecturer, Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University
• April 2016-March 2020: Assistant Professor, Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University
• October 2014-March 2016: Specific Assistant Professor, Medical Education Center, Osaka University
• April 2012-September 2014: Specific Assistant Professor Interdisciplinary Program for Biomedical Sciences (IPBS), Osaka University
• April 2011-March 2012: Specific Researcher, Department of Molecular Biology and Biochemistry, Graduate School of Medicine, Osaka University
• April 2007-March 2011: Assistant Professor, Division of Oral Rehabilitation, Kyushu University Hospital
• 2003: Dentist Licensed by Japanese Government

• 2021 The Japanese Society of Pathology. A lecture.
• 2006 The Japanese Society of Conservative Dentistry. Encouragement Award.

1. Fujii, S (corresponding author)., Ishibashi, T., Kokura, M., Fujimoto, T., Matsumoto, S., Shidara, S., Kari K., J Pape., J Caton., Peter M., K Heikinheimo., Kikuchi, A., Jimi, E., Kiyoshima, T. (2022): ARL4C expression, due to RAF1-MEK/ERK pathway, promotes ameloblastoma cell proliferation and osteoclast formation. J Pathol. 256: 119-133
2. Fujii S (corresponding author)., Fujimoto T., Hasegawa K., Nagano R., Ishibashi T., Kurppa K., Mikami Y., Kokura M., Tajiri Y., Kibe T., Wada H., Wada N., Kishida S., Higuchi Y., Kiyoshima T. (2022): The Semaphorin 3A-AKT axis-mediated cell proliferation in salivary gland morphogenesis and adenoid cystic carcinoma pathogenesis. Pathol Res Pract. 236: 153991
3. Hasegawa K., Fujii S (co-first)., Kurppa K., Maehara T., Oobu K., Nakamura S., Kiyoshima T. (2022): Clear cell squamous cell carcinoma of the tongue exhibits characteristics as an undifferentiated squamous cell carcinoma. Pathol Res Pract. 235:153909
4. Nagano R., Fujii S (corresponding author)., Hasegawa K., Maeda H., Kiyoshima T. (2022): Wnt signaling promotes tooth germ development through YAP1-TGF-β signaling. Biochem Biophys Res Commun. 630: 64-70
5. Hasegawa, K., Fujii, S (corresponding author)., Matsumoto, S., Tajiri, Y., Kikuchi, A., Kiyoshima, T. (2021): YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation. J Pathol. 253: 80-93
6. Fujii, S (corresponding author)., Tajiri, Y., Hasegawa, K., Matsumoto,S., Yoshimoto, RU., Wada, H., Kishida, S., Kido, MA., Yoshikawa, H., Ozeki, S., Kiyoshima, T. (2020): The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation. Lab Invest. 2: 311-323
7. Fujii, S (corresponding author)., Nagata, K., Matsumoto, S., Kohashi, K., Kikuchi, A., Oda, Y., Kiyoshima, T., Wada, N. (2019): Wnt/β-catenin signaling, which is activated in odontomas, reduces Sema3A expression to regulate odontogenic epithelial cell proliferation and tooth germ development. Sci Rep. 9: 4257
8. Mikami, Y., Fujii, S (co-first)., Nagata, K., Wada, H., Hasegawa, K., Abe, M., Yoshimoto, RU., Kawano, S., Nakamura, S., Kiyoshima, T. (2017): GLI-mediated Keratin17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas. J Cancer Res Clin Oncol. 143: 1382-1393

Keynote

Associate Professor

University of Malaya

oral pathology

29/03/2004: ERALA UNIVERSITY, INDIA.  MDS (Oral Pathology)            

23/03/1998: AMIL NADU Dr. M.G.R. MEDICAL UNIVERSITY.  BDS                         

24/08/2018 - (Lifetime Membership): Malaysian Society of Oral Microbiologists and Oral Immunologists 

1. Haron, N., Rajendran, S., Kallarakkal, T. G., Zain, R. B., Ramanathan, A., Abraham, M. T., ... & Cheong, S. C. (2021). High referral accuracy for oral cancers and oral potentially malignant disorders using telemedicine. Oral diseases. (2021)
2. Hamzan, N. I., Rahman, N. A., Suraiya, S., Mohamad, I., Kalarakkal, T. G., & Mohamad, S. (2021). Real-Time Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Human Papillomavirus 16 in Oral Squamous Cell Carcinoma. Archives of Oral Biology, 105051. (ISI-Indexed) (2021)
3. Roshan Alex Welikala, Paolo Remagnino, Jian Han Lim, Chee Seng Chan, Senthilmani Rajendran, Thomas George Kallarakkal, Rosnah Binti Zain, Ruwan Duminda Jayasinghe, Jyotsna Rimal, Alexander Ross Kerr, Rahmi Amtha, Karthikeya Patil1, Wanninayake Mudiyanselage Tilakaratne, John Gibson, Sok Ching Cheong and Sarah Ann Barman. Automated Detection and Classification of Oral Lesions using Deep Learning for Early Detection of Oral Cancer. IEEE Access;2020;8:132677-132693 (ISI-Indexed) (2020)
4. Zain, R. B., Pateel, D. G. S., Ramanathan, A., Kallarakkal, T. G., Wong, G. R., Yang, Y. H., ... & Durward, C. (2020). Effectiveness of OralDETECT : a Repetitive Test-enhanced, Corrective Feedback Method Competency Assessment Tool for Early Detection of Oral Cancer. Journal of Cancer Education, 1-9. (ISI-Indexed) (2020)
5. Welikala, R. A., Remagnino, P., Lim, J. H., Chan, C. S., Rajendran, S., Kallarakkal, T. G., ... & Amtha, R. (2020, October). Fine-Tuning Deep Learning Architectures for Early Detection of Oral Cancer. In International Symposium on Mathematical and Computational Oncology (pp. 25-31). Lecture Notes in Computer Science, vol 12508. Springer, Cham. (ISI-Indexed) (2020)
6. Tegginamani, A. S., Shivakumar, V. H., Kallarakkal, T. G., Ismail, S. M., Abraham, M. T., & Zamzuri, A. T. B. (2020). Analysis of octamer-binding transcription factor-4 expression in oral leukoplakia. Journal of Oral and Maxillofacial Pathology, 24(2), 400. (SCOPUS-Indexed) (2020)
7. Tegginamani, A. S., Kallarakkal, T. G., Vanishree, H. S., & Muttalib, K. B. A. (2019). Analysis of CD 133 Expression in Oral Leukoplakia. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP, 29(7), 688-688. (ISI-Indexed) (2019)
8. Ghani, W. M. N., Ramanathan, A., Prime, S. S., Yang, Y. H., Razak, I. A., Abdul Rahman, Z. A., Abraham M.T., Mustafa, W.M.W., Tay,K.K., Kallarakkal, T.G. & Doss, J. G. (2019). Survival of Oral Cancer Patients in Different Ethnicities. Cancer investigation, 37(7), 275-287. (ISI-Indexed) (2019)
9. Fauzia, F. H., Hamzana, N. I., Rahmana, N. A., Mohamadb, I., Suraiyac, S., Kallarakkal, T. G., & Mohamada, S. (2019). Detection of human papillomavirus types 16 and 18 in oral squamous cell carcinoma samples in Malaysia. Archives of Orofacial Science, 14(1) (Non-ISI/Non-SCOPUS (2019)
10. Chher, T., Hak, S., Kallarakkal, T. G., Durward, C., Ramanathan, A., Ghani, W. M. N., ... & Prak, P. (2018). Prevalence of oral cancer, oral potentially malignant disorders and other oral mucosal lesions in Cambodia. Ethnicity & health, 23(1), 1-15. (2018)
11. ABDELRAHIM, L. M., Peh, S. C., & Kallarakkal, T. G. (2018). Epstein-Barr virus infection in B-cell Non-Hodgkin's Lymphomas of the oral and maxillofacial region: Is there any evidence?. The Malaysian journal of pathology, 40(1), 49-56. (2018)
12. Zulkiffli, S., & Kallarakkal, T. G. (2017). Prevalence of Oral Potentially Malignant Disorders and Awareness on Oral Cancer among Dental Patients. Annals of Dentistry University of Malaya, 23(1), 38-47. (2017)
13. Vincent-Chong, VK., Salahshourifar, I., Woo, KM., Anwar, A., Razali, R., Gudimella, R., Rahman, ZA., Ismail, SM., Kallarakkal, TG., Ramanathan, A., Wan Mustafa, WM., Abraham MT, Tay, KK., Zain, RB,. (2017 Apr). Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance. PLoS One. 6;12(4):e0174865. doi: 10.1371/journal.pone.0174865. eCollection 2017. PubMed PMID: 28384287; PubMed Central PMCID: PMC5383235. (2017)
14. Kazakydasan, S., Rahman, Z. A. A., Ismail, S. M., Abraham, M. T., & Kallarakkal, T. G. (2017). Prognostic significance of VEGF‐C in predicting micrometastasis and isolated tumour cells in N0 oral squamous cell carcinoma. (2017)
15. Haron, N., Zain, R. B., Nabillah, W. M., Saleh, A., Kallarakkal, T. G., Ramanathan, A., ... & Cheong, S. C. (2017). Mobile phone imaging in low resource settings for early detection of oral cancer and concordance with clinical oral examination. (2017)
16. SNI, S. O., Mazlam, N., & Kallarakkal, T. G. (2016). Evaluation of Carbamazepine Pharmacotherapy In Patients With Trigeminal Neuralgia. Annals of Dentistry University of Malaya, 23(2), 20-27. (2016)
17. Chan, S. W., Liew, L. H., Wong, G. R., Kallarakkal, T. G., Abraham, M. T., Ramanathan, A., & Zain, R. B. (2016). Audit of Turnaround Time for a Training Oral Histopathology Laboratory in Malaysia. International journal of surgical pathology, 1066896916639372. (2016)
18. Fadlullah, M. Z., Chiang, I. K., Dionne, K. R., Yee, P. S., Gan, C. P., Sam, K. K., ... & Kallarakkal, T. G. (2016). Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. Oncotarget, 7(19), 27802. (2016)
19. Lee, C. E., Vincent-Chong, V. K., Ramanathan, A., Kallarakkal, T. G., Karen-Ng, L. P., Ghani, W. M. N., ... & Mustafa, W. M. W. (2015). Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications. International Journal of Medical Sciences, 12(12), 937. (2015)
20. Auzair, L. B. M., Vincent-Chong, V. K., Ghani, W. M. N., Kallarakkal, T. G., Ramanathan, A., Lee, C. E., ... & Zain, R. B. (2015). Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC). European Archives of Oto-Rhino-Laryngology, 1-9. (2015)

Keynote

Associate Professor

Department of Oral Pathology, School of Dentistry, Pusan National University

Oral Pathology

• 2000-2008: Ph.D. in Neuroscience
  The University of Iowa, Graduate College, Iowa City, Iowa, U.S.A.
• 1998-2000: M.M.S. in Neurophysiology
  Seoul National University, College of Medicine, Seoul, Korea
• 1992-1998: D.D.S.
  Pusan National University, College of Dentistry, Pusan, Korea
  (Holder of Dental License: no. 15901)

• 2013-2017.2: Assistant Professor, Department of Oral Pathology, Department of Life Science in Dentistry School of Dentistry, Pusan National University, Korea
• 2008-2013.1: Postdoctoral Fellow/Research Scientist
  The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts, U.S.A

• 2018-2021: Basic Science Research Program, the National Research Foundation of Korea, the Ministry of Science and ICT
• 2015-2018: SGER Grant, Basic Science Research Grant, the National Research Foundation of Korea, the Ministry of Education, Science and Technology
• 2013-2016: Basic Science Research Grant, the National Research Foundation of Korea, the Ministry of Education, Science and Technology

1. Joohyung Kim, Sungdae Kim, Minyeop Nahm, Tsai-Ning Li, Hsin-Chieh Lin, Yeongjin David Kim, Jihye Lee, Chi-Kuang Yao and Seungbok Lee. ALS2 regulates endosomal trafficking, postsynaptic development, and neuronal survival. J Cell Biol. 220(5):e202007112 (2021).
2. Jae Yeong Ha, Song-Yi Choi, Ji Hye Lee, Su-Hyung Hong and Heon-Jin Lee. Delivery of Periodontopathogenic Extracellular Vesicles to Brain Monocytes and Microglial IL-6 Promotion by RNA Cargo. Front Mol Biosci. 7:596366 (2020).
3. Ji Eun Jung, Joo Young Lee, In Ryoung Kim, Sang Mee Park, Ji Wan Kang, Yun Hak Kim, Hae Ryoun Park and Ji Hye Lee*. MicroRNA-31 Regulates Expression of Wntless in Both Drosophila melanogaster and Human Oral Cancer Cells. Int J Mol Sci, 21(19):7232 (2020).
4. Joo-Young Lee, Ji Hye Lee* and Chong Kun Cheon*. Functional Characterization of Gomisin N in High-Fat-Induced Drosophila Obesity Models. Int J Mol Sci, 21(19):7209 (2020).
5. Yong-Gun Kim, Myoung Ok Kim, Sung-Hyun Kim, Hyo Jeong Kim, Nitin Kumar Pokhrel, Ji Hye Lee, Heon-Jin Lee, Jae-Young Kim and Youngkyun Lee. 6-Shogaol, an active ingredient of ginger, inhibits osteoclastogenesis and alveolar bone resorption in ligature-induced periodontitis in mice. J Periodontol. 91(6):809-818 (2019).

Keynote

Professor

University of Chicago

Pathology

• BA Zoology, DePauw University
• DDS, Northwestern University Dental School
• PhD, Northwestern University Feinberg School of Medicine
• Oral & Maxillofacial Pathology Residency, Northwestern University Dental School

• 1996-1998: Assistant Professor, Department of Pathology, Northwestern University, Feinberg School of Medicine
• 1998-2001: Assistant Professor, Departments of Pathology and Otolaryngology, Loyola University Medical Center
• 2001-2002: Associate Professor, Departments of Pathology and Otolaryngology, Loyola University Medical Center
• 2002-2012: Associate Professor, Departments of Pathology, University of Chicago
• 2012-Present: Professor, Departments of Pathology, University of Chicago

1. Salouraa V, Izumchenkob E, Zuoc Z, Bao R, Korzinkinf M, Ozerovf I, Zhavoronkovf A, Sidransky D, Bedig A, Hoqueg MO, Koeppenh H, Keck MK, Khattri A, London N, Kotlovi N, Fatimab A, Vougiouklakis T, Nakamuraj Y, Lingen MW, Agrawal N, Savage PA, Kron S, Kline J, Kowanetz M, Seiwert TY. 2019. Immune profiles in primary squamous cell carcinoma of the head and neck. Oral Oncology, 96:77-88.
2. Schubert AD, Broner EC, Agrawal N, London N, Pearson A, Gupta A, Wali N, Seiwert TY, Wheelan S, Lingen MW, Macleod K, Allen H, Chatterjee A, Vassiliki S, Gaykalova D     Hoque M, Sidransky D, Suresh K, Izumchenko E. 2020. Somatic mitochondrial mutation discovery using ultra-deep sequencing of the mitochondrial genome reveals spatial tumor heterogeneity in head and neck squamous cell carcinoma. Cancer Letters, 471:49-60
3. Chaturvedi AK, Udaltstova N, Engels EA, Katzel JA, Yanik EL, Katki HA, Lingen MW, Silverberg MJ. 2020. Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-based Cohort Study. Journal of the National Cancer Institute, 112:1047-1054.
4. Shanmugam A, Hasina R, Hariharan AK, Nair K, Katragadda S, Irusappan S, Ravichandran A, Veeramachaneni V, Bettadapura R, Bhati M, Ramaswamy V, Rao V, Bagadia R, Manjunath NML, Solomon MC, Maji S, Bahadur U, Bettegowda C, Papadopoulos N, Lingen MW, Hariharan R, Gupta V, Agrawal N, Izumchenko E. 2021. Ultra-sensitive detection of somatic mutations in saliva of patients with oral cavity squamous cell carcinoma. Cancer, 127:1576-1589.
5. Thompson LDR, Fitzpatrick SG, Müller S, Eisenberg E, Upadhyaya JD, Lingen MW, Nadarajah V, Woo SB, Bhattacharyya I, Bilodeau EA, Carlos R, Islam MN, Leon ME, Lewis JS, Magliocca KR, Mani H, Mehrad M, Purgina B, Richardson M, Wenig BM, Cohen DM. 2021. Proliferative Verrucous Leukoplakia: An expert consensus guideline for standardized assessment and reporting. Head and Neck Pathology, 15:572-587.

Dr. Mark Lingen is a Professor of Pathology and Medicine at the University of Chicago Medicine. He is a graduate of Northwestern University Dental School. He also completed a residency in Oral & Maxillofacial Pathology and earned a PhD in Cellular and Molecular Pathology at Northwestern University. Dr. Lingen is the Editor-in-Chief for the journal Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology (Triple O). He is a Fellow of the American Academy of Oral & Maxillofacial Pathology, the American and International Colleges of Dentists, and the Royal College of Pathologists. Dr. Lingen is a Diplomate of the American Board of Oral & Maxillofacial Pathology. He is a Past President of the American Academy of Oral & Maxillofacial Pathology (AAOMP) and the current President of the International Association of Oral & Maxillofacial Pathology (IAOP). Dr. Lingen’s NIH-funded research, which focusses on several aspects of oral cancer, has resulted in more than 200 manuscripts and book chapters.

Keynote

Professor

Department of Oral Pathology/Forensic Odontology, School of Dentistry, Aichi Gakuin University

Oral Pathology and Oral Medicine

• 1984: Ph.D., Department of Pathology, School of Dentistry, Aichi Gakuin University
• 1980: D.D.S., Aichi Gakuin University, School of Dentistry

• 2018-present: President of The Japanese society of Oral Pathology
• 2016-present: Visiting Professor of School of Dentistry, Hiroshima University
• 2012: External examiner in Oral Medicine and Oral Pathology, Faculty of Dentistry, University of Malaya, Kuala Lumpur

• 2012: President Award from the government of Mongolia for investigating human papilloma virus infection (HPV) in the young people of Mongolia

1. Kinoshita Y, Maeda H：Chapter 12 Scientific Review on the Recent Developments of Functional Scaffolds for Craniomaxillofacial Bone Tissue Engineering Applications. In Mohd Rafatullah ed, Recent Advances in Science and Technology Research vol.3, Book Publisher International （London）, 120-148, 2020.
2. Saman Warnakulasuriya, Maeda H, John S Greenspan： 7 Pathology of Oral and Oropharyngeal Cancers. In Saman Warnakulasuriya, John S Greenspan eds, Textbook of Oral Cancer Prevention, Diagnosis and Management. Springer Nature Switzerland AG, Cham, Switzerland, 70-79, 2020.
3. Hasegawa M, Saruta J, Hirota M, Taniyama T, Sugita Y, Kubo K, Ishijima M, Ikeda T, Maeda H, Ogawa T： A newly created meso-, micro-, and nano-scale rough titanium surface promotes bone-implant integration. Int J Mol Sci. 21(3): 783, 2020.
4. Sugita Y, Okubo T, Saita M, Ishijima M, Torii Y, Tanaka M, Iwasaki C, Sekiya T, Tabuchi M, Naser Mohammadzadeh Rezaei, Taniyama T, Sato N, Saruta J, Hasegawa M, Hirota M, Wonhee Park, Masaichi Chang-Il Lee, Maeda H, Ogawa T: Novel osteogenic behaviors around hydrophilic and radical-free 4 META/MMA-TBB: implications of an osseointegrating bone cement, Int J Mol Sci, 21(7): 2405, 2020.
5. Utsumi M, Moriguchi K, Kato A, Kondo H, Maeda H: Ultrastructural study of the age-dependent effects of the alendronate sodium hydrate treatment on the parathyroid gland in golden hamsters. J Hard Tissue Biol, 29(3), 147-150, 2020.

Keynote

Assistant Professor, University of Toronto
Staff oral pathologist, Sunnybrook Health Sciences Centre

1. Faculty of Dentistry, University of Toronto
2. Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto
3. Institute of Medical Science, Faculty of Medicine, University of Toronto
4. Sunnybrook Health Sciences Centre

Cancer cell biology

• 2005: DDS, Universidade Federal de Goias, Brazil
• 2009: PhD, University of Toronto
• 2011: Postdoctoral Fellow, Albert Einstein College of Medicine, NY
• 2015: MSc, Oral pathology and Oral Medicine, University of Toronto

• 2015-present Assistant Professor
  Tenure-stream
  Oral Pathology and Oral Medicine Department
  Faculty of Dentistry, University of Toronto
• 2015-present Assistant Professor, cross-appointed
  Laboratory Medicine and Pathobiology
  University of Toronto
• 2020-present Assistant Professor, cross-appointed
  Institute of Medical Sciences
  University of Toronto
• 2015- present Staff Oral Pathologist (Active staff)
  Department of Dentistry
  Sunnybrook Health Sciences Centre
• 05-2021-present Full Member
  Graduate Department of Dentistry
  School of Graduate Studies, University of Toronto
• 2015-2021 Associate Member
  Graduate Department of Dentistry
  School of Graduate Studies, University of Toronto

• 2019 Early Career Investigator (ECI) Program award supported by the Canadian Institutes of Health Research-Institute of Cancer Research (CIHR-ICR) and Ontario Institute for Cancer Research (OICR). This award provided financial support to attend the Canadian Cancer Research Conference and CIHR ECI meeting.
• 2018 Connaught New Investigator Award, University of Toronto. $10,000 competitive award for new investigators at the University of Toronto
• 2018 Canadian Institutes of Health Research (CIHR) observer program for early career researchers. This program is designed as an opportunity for selected Early Career Researchers to observe face-to-face peer review committee meetings and gain valuable insights on the review process.
• 2017 Moments of Service Excellence
  Sunnybrook Moment of Service Excellence certificates are awarded by the Office of the Patient Experience of Sunnybrook hospital in honour of outstanding service and dedication to patients.
• 2016 Canadian Cancer Society – Great Canadian Innovation Grant of the year. This grant has been named as the Canadian Cancer Society’s 2nd annual Great Canadian Innovation Grant. According to the CCS website: “We launched this exciting campaign to engage Canadians directly in cancer research last year, and it was such a success that we did it again this year. “The Great Canadian Innovation Grant is a reflection of the strength we have when we come together from coast to coast to support Canadians affected by cancer.”
• 2014 Gorlin Award for Best oral abstract presentation
  The American Academy of Oral and Maxillofacial Pathology Gorlin Award. This award is in recognition of outstanding oral pathology residents presenting their research at the annual meeting. American Academy of Oral and Maxillofacial Pathology (AAOMP) meeting, Saint Augustine, FL
• 2014 Canadian Association of Oral Maxillofacial Pathology and Oral Medicine (CAOMPOM) resident presentation award. This award is for the oral pathology resident presenting clinical cases at the CAOMPOM interim general meeting, Saint Augustine, FL
• 2013 Canadian Association of Oral Maxillofacial Pathology and Oral Medicine (CAOMPOM) resident presentation award. This award is for the oral pathology resident presenting clinical cases at the CAOMPOM interim general meeting, Portland, OR
• 2012 Javenthey Soobiah Scholarship – Postgraduate Medical Research Award, University of Toronto. This scholarship is to provide financial assistance to postgraduate trainees engaged in medical research
• 2012 Heidi Sternbach Scholarship - Postgraduate Medical Research Award, University of Toronto. This scholarship is to provide financial assistance to postgraduate trainees engaged in medical research
• 2010 American Society for Cell Biology Travel Award – This award provides financial support to graduate students presenting their research at the general annual meeting. 50th general meeting, Philadelphia, PA, USA
• 2010 Pivotal Advance and Editorial in Journal of Leukocyte Biology. Paper: Pivotal Advance: Phospholipids determine net membrane surface charge resulting in differential localization of active Rac1 and Rac2. J Leukoc Biol. 2010 Apr;87(4):545-55. PMID: 19955208 (46 citations as of March 2021)
• 2010 ESF-EMBO Travel Award
  European Science Foundation Travel Award – Emerging properties of the Cytoskeleton: Molecules to Cells - Spain
• 2009 IADR/ Unilever Hatton Divisional Award – Senior Basic Science category. International Association for Dental Research, 87th General Session, Miami, USA
• 2008 Canadian Association for Dental Research CADR/IMHA Student Research Award
  Awarded the first place in the Senior, basic science category.
• 2007 Wilson G. Harron Scholarship
  This scholarship is offered to applicants with excellent academic records that will pursue an academic career. Faculty of Dentistry, University of Toronto (2007-2009)
• 2007 CIHR Strategic Training Fellow - Cellsignals
  This Canadian Institutes of Health Research program supported PhD students in the area of cell biology, microbiology and matrix biology

1. Laliberte C, Ng N, Eymael D, Ali A, Bradley G, Magalhaes M. A Pilot Study of the Inflammatory Response in Oral Squamous Cell Carcinoma by Saliva Analysis. Frontiers in Oral Health, 2021, in press
2. Chadwick J, MacDonald R, Ali A, Glogauer G, Magalhaes M. TNF and TNFR1 expression in progressing oral potentially malignant disorders and their role in the regulation of malignant transformation in 4NQO-induced carcinogenesis. Frontiers in Oncology, 2021, in press
3. Kierce J, Shi Y, Klieb H, Blanas N, Xu W, Magalhaes M. Identification of specific clinical risk factors associated with the malignant transformation of oral epithelial dysplasia Head and Neck, 2021, in press
4. McCord, A. Kiss, M. Magalhaes, I. Leong, T. Jorden, G. Bradley. Oral and oropharyngeal squamous cell carcinoma associated with precursor lesions: a study of cancer data in ontario, Canada. Cancer Prevention Research, 2021
5. Dave, K., Ali, A., & Magalhaes, M. (2020). Increased expression of PD-1 and PD-L1 in oral lesions progressing to oral squamous cell carcinoma: a pilot study. Scientific Reports, 10(1), 9705. doi:10.1038/s41598-020-66257-6
6. Ali, A., Soares, A. B., Eymael, D., & Magalhaes, M. (2020). Expression of invadopodia markers can identify oral lesions with a high risk of malignant transformation. J Pathol Clin Res. doi:10.1002/cjp2.182
7. Goertzen, C., Mahdi, H., Laliberte, C., Meirson, T., Eymael, D., Gil-Henn, H., & Magalhaes, M. (2018). Oral inflammation promotes oral squamous cell carcinoma invasion. Oncotarget, 9(49), 29047-29063. doi:10.18632/oncotarget.25540

Dr. Marco Magalhaes is a clinician-scientist, director of the Cancer Invasion and Metastasis Laboratory (CIMlab) and assistant professor at the Faculty of Dentistry, cross-appointed to Laboratory Medicine and Pathology and Institute of Medical Sciences, Faculty of Medicine. Dr. Magalhaes received his PhD in cell biology at the University of Toronto in 2009 and completed a postdoctoral fellowship at the Albert Einstein College of Medicine Cancer Centre before returning to the University of Toronto to complete his residency in Oral Pathology and Oral Medicine. Dr. Magalhaes currently has several research projects in the area of oral potentially malignant disorders and oral cancer and is a staff oral pathologist at Sunnybrook Health Sciences Centre. His main area of interest is the role of immune cells and mediators in the progression of oral cancer. He is a Diplomate of the American Board of Oral and Maxillofacial Pathology, fellow of the American Academy of Oral and Maxillofacial Pathology, and a Fellow of the Royal College of Dentists of Canada.

Keynote

Honorary Consultant Histopathologist and Emeritus Professor of Oral Pathology and Medicine 

Guy’s and St Thomas’ NHS Trust and King’s College London

Oral and Maxillofacial Pathology

Studied dentistry at the Royal London Medical College, PhD University College London, Pathology training at Guy’s Hospital London

I have worked in Oral and Maxillofacial Pathology since 1982 and been Head of Department at Guy’s and St Thomas’ Hospitals since 2005. I have worked in both Oral Pathology and Oral Medicine. 

President International Association of Oral and Maxillofacial Pathologists 2018-2020

1. Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Dis. 2021 Aug 21. doi: 10.1111/odi.13993. Epub ahead of print. PMID: 34418233.
2. King, C., et al. (2021). Serial step sections at narrow intervals with immunohistochemistry are required for accurate histological assessment of sentinel lymph node biopsy in oral squamous cell carcinoma. Head Neck  43(10):2985-2993. doi: 10.1002/hed.26784. Epub 2021 Jun 15. PMID: 34128276
3. Carey, B. et al. (2021). Eosinophilic sialodochitis: An emerging atopic condition. Oral Dis. doi: 10.1111/odi.13821. Epub ahead of print. PMID: 33660371
4. Odell E. W. (2021). Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral diseases, 10.1111/odi.13797. Advance online publication. https://doi.org/10.1111/odi.13797
5. Coura BP, et al. (2020). Targeted next-generation sequencing and allele-specific qPCR of laser capture microdissected samples uncover molecular differences in mixed odontogenic tumors. J Mol Diagn. 2020 Sep 20:S1525-1578(20)30460-8. doi: 10.1016/j.jmoldx.2020.08.005. Epub ahead of print. PMID: 32966885.
6. Sathasivam, H. P. et al. (2021). Dysplasia and DNA ploidy to prognosticate clinical outcome in oral potentially malignant disorders. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 50(2), 200–209. https://doi.org/10.1111/jop.13121

Prof Odell has been extensively involved nationally in education, assessment and regulation of the specialty of oral pathology and dental undergraduate education. He is author of several textbooks including Cawson’s Essentials of Oral Pathology and Medicine.  He has particular interest in dysplasia and odontogenic tumours  and has been involved in the last three editions of the WHO International classification of diseases as author, a member of the consensus group and currently a member of the specialist editorial panel.  He has published over 180 peer-reviewed research publications and five textbooks.  He was lead tumour board pathologist for the Guy’s and St Thomas’ NHS Trust for Head and Neck Pathology until 2016.

Keynote

Professor

Department of Oral Pathology, School of Dentistry, Pusan National University

Oral Pathology, oral cancer, association between periodontitis and systemic diseases

• D.D.S., School of Dentistry, Pusan National University
• 1995. Ph.D., School of Dentistry, Pusan National University

• 2018 – present: Director, Periodontal Disease Signaling Network Center
• 2003-2004: Visiting fellow, Department of Pharmacy, School of Medicine, Emory University, USA

2006: Best researcher awards, Association of Oral and Maxillofacial Pathology

1. Rho JH, Kim HJ, Joo JY, Lee JY, Lee JH, Park HR. 2021. Periodontal Pathogens Promote Foam Cell Formation by Blocking Lipid Efflux. J Dent Res. doi: 10.1177/00220345211008811. Online ahead of print.
2. Yu MR, Kim HJ, Park HR. 2020. Fusobacterium nucleatum accelerates the progression of colitis-associated colorectal cancer by promoting EMT. Cancers (Basel). 12(10):E2728. doi: 10.3390/cancers12102728.
3. Kim DJ, Rho JH, Woo BH, Joo JY, Lee JY, Song JM, Lee JH, Park HR. 2019. Periodontal pathogens modulate lipid flux via fatty acid binding protein 4. J Dent Res. 98(13):1511-1520. doi: 10.1177/0022034519880824.

Hae Ryoun Park graduated from School of Dentistry, Pusan National University in 1991 and got a Ph.D degree from the same university in 1995. HR Park has been teaching oral pathology since 1998. Interest of studies are effects of chronic periodontitis on oral cancer progression including invasive and metastatic abilities. In addition, Hae Ryoun Park is leading a seven-year, $ 9.5 million Medical Research Center program of Basic Science Research Grant funded by the National Research Foundation of Korea. The research team is investigating the role of periodontal pathogens, especially Porphyromonas gingivalis, in the development of various systemic diseases as well as the correlation between chronic periodontitis and systemic diseases.

Keynote

Professor

The University of British Columbia

Oral Pathology/ Oral Medicine

• 2004-2006: Post-doctoral Fellowship, Oral Cancer Prevention, Cancer Control Research Program, BC Cancer Research Centre
• 2001-2004: Certificate, Oral Medicine and Oral Pathology Residency, The University of BC
• 1997-2001: PhD, Molecular study of oral cancer and precancers, The University of BC

• 2005/10: Diploma, Oral and Maxillo-facial Pathology, American Board of Oral Maxillofacial Pathology
• 2005/09: Fellow, Oral Pathology, Royal College of Dentists of Canada
• 2004-2006: Clinical Research Fellow, Cancer Control Research Program, BC Cancer Agency/Research Centre

• 2017 Awards for Scholarship: UBC’s Killam Award for Excellence in Mentoring (Mid-Career Category) Nomination, Department Head, Department of Oral Biological and Medical Sciences (UBC to recognize outstanding mentorship ofnumerous graduate students over many years.)
• 2010: Visiting Professorship Award from Canadian Association of Dental Research-Quintessence and Association of Canadian Faculties of Dentistry
• 2009: W. W. Wood Teaching Award (Department Head Nomination)

1. X.J. David Lu, Kelly Y.P. Liu, Eitan Prisman, Jonn Wu, Yuqi Sarah Zhu, Catherine F. Poh. Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients. American Journal of Surgical pathology. 2020 (Under review)
2. X. J. David Lu, Emmanuel Jackson, Jason Chew, Sally Nguyen, Jonn Wu, Catherine F. Poh, Eitan Prisman. Does the Data Support Treatment De-escalation for Oropharyngeal Cancer Patients? A Population-based Retrospective Analysis. Oral Oncology. 2020 (Under review)
3. Liu KYP, Zhu SY, Brooks D, Bowlby R, Durham JS, Ma Y, Moore RA, Mungall AJ, Jones S, POH CF. Tumour microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients. Oncotarget. 2020 (In Revision)
4. Parfenova K, Zhu S, Carraro A, Guillaud M, POH CF. Potential application of image cytometry in oral cancer screening Oral Cancer Screening Using Image Cytometry. Cyto 2019. June 22-26, Vancouver, Canada (International Conference; Oral Presentation)
5. Liu KYP, Carraro A, Dong E, Hu A, Guillaud M, POH CF. Novel Definition of Field Cancerization Using Quantitative Tissue Phenotype Analysis. 97th General Session of IADR/48th Annual Meeting of AADR/ 43rd Annual Meeting of CADR. June 19-22, 2019. Vancouver, BC. (International Conference; poster presentation)

Keynote

Dr.

Professor & Head of the Department of Oral and Maxillofacial Pathology, Ragas Dental College, Chennai

Oral Cancer, Pre-cancer, OSF, HIV, Stem cell research

• 1987: BDS, Madras University
• 1990: M.D.S., The Tamil Dr.MGR Medical University
• 1996: M.S., Ohio State University, USA
• 2010: PhD, The Tamil Dr.MGR Medical University 

• Current:
  * President, Asian Society of Oral and Maxillofacial Pathology(ASOMP)
  * Secretary, International  Association of Oral Pathologist (IAOP)
  * Chairperson, Fellowship committee, Indian Association of Oral & Maxillofacial Pathology
• 1995:  Fellow American Academy of Oral and Maxillofacial Pathology 
• 2010: Fellow Indian Association of Oral and Maxillofacial Pathologists 
• First Indian Oral Pathologist to hold the post
  Post held in the Past:
  * President, Indian Association of Oral & Maxillofacial Pathology
  * Hon. Secretary, Indian Association of Oral & Maxillofacial Pathology
  * Asian councilor International Association of Oral Pathology 
• Academic Responsibilities:
  * PhD guide: The TN MGR medical University, Chennai Sri Ramachandra Medical University 
  *Member, Board of studies: Dr.NTR University, Andhra Pradesh 
  *Faculty appraisal: University of Peradeniya, Srilanka 
  *Visiting Professor: University of Malaya, Malayasia 

• II BDS:  Colgate Palmolive Scholarship (University First)
• III BDS:  Colgate Palmolive Scholarship (University First)
• IV BDS:  Indian Dental Assoc. Gold Medal (University Best Student)
• 1983-84:  University Gold Medal-Dr. Govinda Menon Gold Medal (Anatomy) 
• 1986-87: University Gold Medal-Dr. Mathias Gold Medal (Oral Surgery) 
• 1986-87: University Gold Medal-Dr. Mathias Gold Medal (Best Outgoing BDS Student)
• 1994 April: Bennett Graduate Research (Best Research Society Annual Research Award Ohio State University, USA)  
• 2011 March: Best Teacher Award (Perpetuating Academic Excellence The TN Dr. MGR Medical University Chennai)

1. Kannan Ranganathan, Loganathan Kavitha, Prakash Sharada,  Radhika M. Bavle, Roopa S. Rao,  Smita M. Pattanshetty , Vinay K. Hazarey,  Murittige Gopalakrishna Madhura , Tejavathi Nagaraj,  Ashok Lingappa,  Saman Warnakulasuriya
   Intra‐observer and inter‐observer variability in two grading systems for oral epithelial dysplasia: A multi‐centre study in India. J Oral Pathol Med. 2020;00:1–8
2. Ranganathan K, Smitha T. COVID - 19 fact sheet for the dental professional. J Oral Maxillofac Pathol 2020;24:8-10
3. Immunohistochemical Biomarkers in Oral Submucous Fibrosis–A Scoping Review. Kavitha L, Ranganathan K, Shyam S, Fathima JH, Umesh W, Warnakulasuriya S. Journal of Oral Pathology & Medicine. 2022 Feb 1
4. K Gayathri, N Malathi,  Gayathri, Pooja Narain Adtani, K Ranganathan, Molecular Pathways Of Oral Submucous Fibrosis And Its Progression To Malignancy, Archives of Oral Biology,2023
5. Vasanthi V, Thavarajah R,Joshua E, Rao UK, Ranganathan K. Evaluation of stress among dental undergraduates and postgraduates using salivary cortisol as a biomarker. Indian J Dent Res 2022;33:263

• 189 Publications 
  * Author: 31
  * Co-Author: 158
• 8 Contributions in Text Book
• 164 Presentations and invited lectures
• 126 Post graduates guided till date
• Journal Referees:  
  * Journal of Oral & Maxillofacial Pathology 
  * Indian Journal of Dental Research 
  * Oral Oncology 
  * Oral Diseases 
  * Oral Cancer, Pre-cancer, OSF, HIV, Stem cell research

IAOP President’s Prize Lectures

Professor Emeritus

University of Hong Kong

Oral Mcirobiomics

DSc (hon), FRCPath, FHKCPath, FDSRCS (Edin) FRACDS, FDS RCPS

Professor emeritus and Immediate-past Dean, Faculty of Dentistry, University of Hong Kong

• Distinguished Scientist Award (Oral Medicine and Pathology), International Association for Dental Research, 2010
• King James IV Professorship (2012-2013), Royal College of Surgeons of Edinburgh, UK
• Lifetime Achievement Award, Sri Lanka Foundation, Los Angeles, USA, 2015
• Distinguished Service Award International Association for Dental Research (Southeast Asian Division), 2013 

Fakhruddin, KS , Samaranayake, LP, Hamoudi, RA et al Hien Chi (2022) Diversity of site-specific microbes of occlusal and proximal lesions in severe- early childhood caries (S-ECC), Journal of Oral Microbiology, 14:1, DOI: 10.1080/20002297.2022.2037832

Samaranayake, LP, Seneviratne, CJ, Fakhruddin, KS. (2022) Coronavirus disease 2019 (COVID-19) vaccines: A concise review. Oral Dis; 28(Suppl. 2): 2326– 2336. https://doi.org/10.1111/odi.13916

Samaranayake, L P; Kausar S. Fakhruddin, Hien C. Ngo, H.M.N.M. Bandara, Y.Y. Leung, (2022) Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review, International Dental Journal,; 72: 607-620 

Seneviratne, C., Jin, L. and Samaranayake, L. (2008), Biofilm lifestyle of Candida: a mini review. Oral Diseases, 14: 582-590. https://doi.org/10.1111/j.1601-0825.2007.01424.x

Bandara, MHMN A Hewavitharana, PN Shaw  H Smyth, Samaranayake LP (2020) A novel, quorum sensor-infused liposomal drug delivery system suppresses Candida albicans biofilms. International Journal of Pharmaceutics. 578. 119096. 10.1016/j.ijpharm.2020.119096.

Professor Emeritus Lakshman `Sam` Samaranayake of the University of Hong Kong, is a renowned clinical academic with expertise in clinical microbiology, research, and executive level administration, and has worked in five different universities in UK, Canada, Hong Kong, Australia, and UAE. With a current h-index of 99, he is the author of over 450 publications, including seminal texts, that have been cited over 31,000 occasions. Being the current Editor-in-Chief of the International Dental Journal. Professor Samaranayake has served over 12 years as the Executive Dean of two major dental schools in Hong Kong and Australia at the Universities of Hong Kong, and Queensland, respectively. A highly sought-after speaker, he has addressed professional bodies in over 40 countries, and received numerous prestigious accolades for his contributions to dentistry, oral medicine and pathology including the coveted King James IV Professorship of the Royal College of Surgeons of Edinburgh, UK, and the Distinguished Scientist Award of IADR, USA.

Keynote

Professor

Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Malaysia

Oral Pathology, Oral Cancer, Oral Potentially Malignant Disorders

• BDS, University of Peradeniya, Sri Lanka
• MS, University of Colombo
• PhD, University of Niigata, Japan

• Past President of the International Association of Oral Pathologists
• Professor of Oral Pathology at Queen Mary University of London
• Former Dean and Senior Professor of Oral Pathology, Faculty of Dental Sciences, University of Peradeniya Sri Lanka

1. RD Jayasinghe, PR Jayasooriya, H Amarasinghe, PVKS Hettiarachchi, BSMS Siriwardena, UKYGDM Wijeratne, SK Kithalawarachchi, WM Tilakaratne. Evaluation of successfulness of capacity buiding programmes on smkokeless tobacco and arecanut cessation. Asian Pac J Cancer Prev, 2021;22(4), 1287-1293. (ISI-Indexed)
2. BSMS Siriwardena, Muthuranwelli Nawaragoda Gedara Pushpakumara Udagama, Tennakoon Tennakoon Mudiyanselage Priyanka Bandara, Demin Achchi Athukoralalage Dona Wimukthi Athukorala, Primali Rukmal Jayasooriya, Wanninayake Mudiyanselage Tilakaratne. Clinical and demographic characteristics of adenomatoid odontogenic tumors: analysis of 116 new cases from a single center (ISI-Indexed)
3. Impact of Histological and Molecular Parameters on Prognosis of Oral Squamous Cell Carcinoma: Analysis of 290 Cases. Siriwardena BSMS, Karunathilaka HDNU, Kumarasiri PVR, Tilakaratne WM. Biomed Res Int. 2020 Oct 14;2020:2059240. doi: 10.1155/2020/2059240 (ISI-Indexed)
4. Tilakaratne WM, Jayasooriya PR, Jayasuriya NS, De Silva RK (2019). Oral epithelial dysplasia: Causes, quantification, prognosis, and management challenges. Periodontol 2000.;80(1):126-147. doi: 10.1111/prd.12259. (ISI-Indexed)
5. Nimna H. Senarath, , Primali R. Jayasooriya, , BSMS. Siriwardena, , Himal N. Kumarage, Saminda Wadusinghearachchi, Pemith Liyanage, Sulochana Wijetunge, Roshitha Waduge, Palitha Ratnayake, W M. Tilakaratne (2019). Inter-examiner Variability in grading of oral epithelial dysplasia may cause suboptimal management of oral potentially malignant disorders. Journal of Dentistry Indonesia, Vol. 26 (1) doi: 10.14693/jdi.v26i1.1317. (Non-ISI/Non-SCOPUS)

Professor WM Tilakaratne BDS, MS, FDSRCS, FRCPath, PhD is currently a Professor attached to the Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya and Department of Oral Pathology, University of Peradeniya. After completing BDS from university of Peradeniya, Sri Lanka he obtained his MS degree from University of Colombo. Then he obtained his professional qualifications from United Kingdom and PhD from University of Niigata, Japan. He has been working as an Oral Pathologist for three decades and held many positions in the field of Oral Pathology. He is a past president of the International Association of Oral Pathologists. He has worked as the Professor of Oral Pathology at Queen Mary University of London and a visiting Professor to many universities in different countries. He was the former Dean and Senior Professor of Oral Pathology, Faculty of Dental Sciences, University of Peradeniya Sri Lanka. Professor Tilakaratne’s main research field is Oral cancer and Oral potentially malignant disorders. He has published over 145 papers with a H-index of 34 and written a text book and contributed to many chapters in internationally recognized text books. He is an editorial board member for many journals as well as for the latest WHO classification on Head and tumours.

Keynote

Full Professor in Oral Pathology

Tel Aviv University

Odontogenic tumors and cysts, Microenvironment of oral cancer

• DMD at the Faculty of Dentistry, Hebrew University, Jerusalem
• Specialty in oral pathology at the Dept. of Oral Pathology, oral Medicine, and Maxillofacial Imaging at the School of Dentistry, Tel Aviv University

In charge of Oral Pathology service, School of Dental Medicine,                 

Tel Aviv University & Institute of Pathology, The Chaim Sheba Medical Center, Tel Hashomer, Israel

Rector of Tel Aviv University award for outstanding teaching

1. Vered M, Wright JM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours. Head Neck Pathol. 2022 Mar;16(1):63-75. doi: 10.1007/s12105-021-01404-7.
2. Hirschhorn A, Abebe Campino G, Vered M, Greenberg G, Yacobi R, Yahalom R, Barshack I, Toren A, Amariglio N, Rechavi G. Upfront rational therapy in BRAF V600E mutated pediatric ameloblastoma promotes ad integrum mandibular regeneration. Journal of Tissue Engineering and Regenerative Medicine 2021; doi: 10.1002/term.3254.
3. Soluk-Tekkesin M, Vered M. Ameloblastic fibro-odontoma: at the crossroad between "developing odontoma" and true odontogenic tumour. Head & Neck Pathology 2021. doi: 10.1007/s12105-021-01332-6
4. Zlotogorski-Hurvitz A, Soluk Tekkeşin M, Passador-Santos F, Martins Montalli VA, Salo T, Mauramo M, Kats L, Buchner A, Vered M. Conceptual changes in ameloblastoma: suggested re-classification of a "veteran" tumor. Oral Diseases 2021; doi: 10.1111/odi.13770.
5. Chacham M, Almoznino G, Zlotogorski-Hurvitz A, Buchner A, Vered M. Expression of stem cell markers in stroma of odontogenic cysts and tumors. J Oral Pathol Med. 2020 Nov;49(10):1068-1077. doi: 10.1111/jop.13102.
6. Graizel D, Zlotogorski-Hurvitz A, Tsesis I, Rosen E, Kedem R, Vered M. Oral cancer-associated fibroblasts predict poor survival: Systematic review and meta-analysis. Oral Dis. 2020 May;26(4):733-744. doi: 10.1111/odi.13140.
7. Silveira FM, Macedo CCS, Borges CMV, Mauramo M, Vasconcelos ACU, Soares AB, Martinez EF, de Araujo VC, Vered M, Salo T, Passador-Santos F. Odontogenic tumors: An 11-year international multicenter study. Oral Dis. 2021 Mar;27(2):320-324. doi: 10.1111/odi.13550.

Marilena Vered obtained her dental degree (DMD) in 1992 at the Faculty of Dentistry, at the Hebrew University in Jerusalem. In 2001 she completed the Oral Pathology training program at the Department of Oral Pathology, Oral Medicine and Maxillofacial Imaging, at the School of Dentistry at Tel Aviv University. She is in charge of the service of oral pathology at the School of Dentistry and at Sheba Medical Center at Tel Hashomer. She has co-authored over 100 articles in international peer-reviewed journals and serves as a reviewer for most of the leading journals in the field of oral pathology and oral medicine. She has been interested in investigating challenging odontogenic lesions and the microenvironment of oral cancer and collaborated with leading researchers in these fields.

Keynote

Associate professor

Division of Oral Pathology, Niigata University Graduate School of Medical and Dental Sciences

Oral Pathology

• Apr 1, 2002-Mar 31, 2006: Doctor of Philosophy, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
• Apr 1, 1995-Mar 31, 2001: Doctor of Dental Surgeon, Faculty of Dentistry, Niigata University

• Apr 1, 2009-Mar 31, 2021: Assistant Professor, Division of Oral Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
• Apr 1, 2006-Mar 31, 2009: Research fellow, National Cancer Center East, Kashiwa, Japan
• Apr 1, 2001-Mar 31, 2001: Resident, Department of Oral Surgery, Sapporo Medical University Hospital, Sapporo, Japan

1. Kiguchi T, Kakihara Y, Yamazaki M, Katsura K, Izumi K, Tanuma JI, Saku T, Takagi R, Saeki M. Identification and characterization of R2TP in the development of oral squamous cell carcinoma. Biochemical and Biophysical Research Communications. vol.548, p.161-166, 2021.
2. Yamazaki M, Maruyama S, Abé T, Tsuneki M, Kato H, Izumi K, Tanuma JI, Cheng J, Saku T. Rac1-dependent phagocytosis of apoptotic cells by oral squamous cell carcinoma cells: A possible driving force for tumor progression. Experimental Cell Research. vol.392, p.112013, 2020.
3. Sakurai K, Tomihara K, Yamazaki M, Heshiki W, Moniruzzaman R, Sekido K, Tachinami H, Ikeda A, Imaue S, Fujiwara K, Noguchi M. CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity. Oral Diseases. vol.26, p.745-755, 2020.
4. Sakurai K, Nakamori K, Yamazaki M, Tanuma JI. An ectomesenchymal chondromyxoid tumour on the lateral border of the tongue. International Journal of Oral and Maxillofacial Surgery. vol.49, p.1290-1293, 2020.
5. Maeda SI, Fujiwara K, Tomihara K, Yamazaki M, Imaue S, Noguchi M. A case of anti‐laminin 332 mucous membrane pemphigoid manifesting as desquamative gingivitis. Oral Science International. vol.18, p.73-77, 2020.

Keynote

Professor

Department of Oral Pathology, Oral Cancer Research Institute

College of Dentistry Yonsei University

Oral Pathology, Oral Cancer

• 1992. 3.-1995. 2.: Ph.D., College of Dentistry Yonsei University
• 1990. 3.-1992. 2.: MS, College of Dentistry Yonsei University
• 1981. 3.-1987. 2.: D.D.S., College of Dentistry Yonsei University

• 2018. 10-present: CEO, MET Life Sciences Ltd. (metls.co.kr)
• 2008. 9.-present: Board member, Korean Academy of Oral and Maxillofacial Pathology
• 2007. 3.-present: Professor, College of Dentistry Yonsei University

1. Kim S, Jeong CH, Song SH, Um JE, Kim HS, Yun JS, Han D, Cho ES, Nam BY, Yook JI, Ku M, Yang J, Kim MD, Kim NH, Yoo TH. Micellized Protein Transduction Domain-Bone Morphogenetic Protein-7 Efficiently Blocks Renal Fibrosis Via Inhibition of Transforming Growth Factor-Beta-Mediated Epithelial-Mesenchymal Transition. Front Pharmacol. 2020, 11, 591275
2. Zhang X, Yun JS, Han D, Yook JI, Kim HS, Cho ES. TGF-β Pathway in Salivary Gland Fibrosis. Int J Mol Sci. 2020, 21, 9138
3. Kim S, Shin DH, Nam BY, Kang HY, Park J, Wu M, Kim NH, Kim HS, Park JT, Han SH, Kang SW, Yook JI*, Yoo TH. Newly designed Protein Transduction Domain (PTD)-mediated BMP-7 is a potential therapeutic for peritoneal fibrosis. J Cell Mol Med. 2020, 24, 13507-22.
4. Choi H, Kim Y, Mirzaaghasi A, Heo J, Kim YN, Shin JH, Kim S, Kim NH, Cho ES, Yook JI, Yoo T-H, Song E, Kim P, Shin E-C, Chung K, Choi K, Choi C. Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality. Sci Adv 2020, eaaz6980
5. Cho ES, Kim NH, Yun JS, Cho SB, Kim HS, Yook JI*. Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism. Cells 2020, 9, 2064.

Keynote

Lecturer

Section of Pathology, Department of Morphological Biology,
Division of Biomedical Sciences, Fukuoka Dental College

Oral Pathology

• 2012-2016: Ph.D., Faculty of Dental Science, Kyushu University, Fukuoka, Japan
• 2011-2012: Resident, General Dentistry, Kyushu University Hospital, Fukuoka, Japan
• 2005-2011: D.D.S., School of Dentistry, Kyushu University, Fukuoka, Japan

• 2016-2020: Assistant Professor, Sect. of pathology, Fukuoka Dental College

• 2020: Fukuoka Public Health Promotion Organization Cancer Research Award
• 2020: The Japan Society of Oral Pathology Encouragement Award
• 2015: The 57th Annual Meeting of Japanese Association for Oral Biology, Poster Award

1. Shohei Yoshimoto, Miho Matsuda, Kenichi Kato, Eijiro Jimi, Hiroshi Takeuchi, Shuji Nakano, Shunichi Kajioka, Etsuko Matsuzaki, Takao Hirofuji, Ryuji Inoue, Masato Hirata, Hiromitsu Morita. Volume-regulated chloride channel regulates cell proliferation and is involved in the possible interaction between TMEM16A and LRRC8A in human metastatic oral squamous cell carcinoma cells. Eur J Pharmacol. Mar 15; 895:173881. doi: 10.1016/j.ejphar.2021.173881. 2021.
2. Hiromasa Anzai, Shohei Yoshimoto, Kazuhiko Okamura, Akimitsu Hiraki, Shuichi Hashimoto. IDO1‐mediated Trp‐kynurenine‐AhR signal activation induces stemness and tumor dormancy in oral squamous cell carcinomas. Oral Sci Int, doi: 10.1002/osi2.1109. 2021.
3. Shohei Yoshimoto, Junko Yoshizumi, Hiromasa Anzai, Koichiro Morishita, Kazuhiko Okamura, Akimitsu Hiraki, Shuichi Hashimoto. Inhibition of Alk signaling promotes the induction of human salivary gland-derived organoids. Dis Model Mech, 13(9), doi: 10.1242/dmm.045054. 2020.
4. Shohei Yoshimoto, Hiromitsu Morita, Miho Matsuda, Yoshinori Katakura, Masato Hirata, Shuichi Hashimoto. NFAT5 promotes the oral squamous cell carcinoma progression in the hyper-osmotic environment. Lab Invest, doi: 10.1038/s41374-020-00486-1. 2020.
5. Tatsuya Abé, Norio Kitagawa, Shohei Yoshimoto, Satoshi Maruyama, Manabu Yamazaki, Tetsuichiro Inai, Shuichi Hashimoto, Takashi Saku. Keratin 17-positive Civatte bodies in oral lichen planus – distribution variety, diagnostic significance, and histopathogenesis. Sci Rep, 10(1), doi: 10.1038/s41598-020-71496-8. 2020.

Keynote

Professor

Chung Shan Medical University

Oral Cancer/Oral Submucous Fibrosis

• 2018-2019: Postgraduate Certificate, Cancer Biology& Therapeutics, Harvard Medical School, USA
• 2005-2009: Ph.D., Institute of Oral Biology, School of Dentistry, National Yang-Ming University, Taiwan

• 2018-2019: Visiting Scholar, Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, USA
• 2021-present: Editorial Board, International Journal of Molecular Sciences
• 2019-present: Editorial Board, Phytomedicine
• 2019-present: Editorial Board, Scientific Reports
• 2019-present: Guest Associate Editor& Review Editor, Frontiers in Oncology
• 2018-present: Editorial Board, Journal of Clinical Medicine
• 2018-present: Editorial Board, Nutrients
• 2018-present: Academic Editor, PeerJ
• 2018-present: Academic Editor, PLOS ONE
• 2018-present: Academic Editor, International Journal of Dentistry

• 2019: Travel Award and selected as the ten finalists, 2019 International & American Associations for Dental Research IADR Joseph Lister Award.
• 2019: Poster Session Chair, IADR／AADR／CADR General Session
• 2019: Co-PI, AAOMP (American Academy of Oral and Maxillofacial Pathology) Research grant
• 2012-present: Ministry of Science and Technology Special Outstanding Talent Award

1. Peng CY, Liao YW, Lu MY, Yang CM, Hsieh PL, Yu CC* (2020). Positive Feedback Loop of SNAIL-IL-6 Mediates Myofibroblastic Differentiation Activity in Precancerous Oral Submucous Fibrosis. Cancers 12:1611.
2. Fang CY, Hsia SM, Hsieh PL, Liao YW, Peng CY, Wu CZ, Lin CK, Tsai LL, Yu CC* (2019). SLUG Mediates Myofibroblastic Differentiation to Promote Fibrogenesis in Buccal Mucosa. J Cell Physiol 234:6721-6730.
3. Yu CC*, Tsai LL, Wang ML, Yu CH, Lo WL, Chang YC, Chiou GY, Chou MY, Chiou SH* (2013). miR145 targets the SOX9/ADAM17 axis to inhibit tumor initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res 73:1-16 (Cited Times:127)
4. Wu MJ, Jan CI, Tsai YG, Yu YH, Huang CY, Lin SC, Liu CJ, Chen YS, Lo JF*, Yu CC* (2010). Targeting Head and Neck Cancer Initiating Cells through Glucose Regulated Protein78 signaling. Mol Cancer 9:283 (Cited Times:116)
5. Chiou SH#, Yu CC#, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF* (2008). Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High Grade Oral Squamous Cell Carcinoma. Clin Cancer Res 14:4085-95. (#Equal Contribution, Cited Times: 710)